Flisiak R - Search Results

1

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.

Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, Dalgard O, Dillion JF, Flisiak R, Forns X, Frankova S, Goldis A, Goulis I, Halota W, Hunyady B, Lagging M, Largen A, Makara M, Manolakopoulos S, Marcellin P, Marinho RT, Pol S, Poynard T, Puoti M, Sagalova O, Sibbel S, Simon K, Wallace C, Young K, Yurdaydin C, Zuckerman E, Negro F, Zeuzem S. Cornberg M, et al. Among authors: flisiak r. Liver Int. 2011 Jul;31 Suppl 2:30-60. doi: 10.1111/j.1478-3231.2011.02539.x. Liver Int. 2011. PMID: 21651702 Review.

2

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.

Buster EH, Hansen BE, Buti M, Delwaide J, Niederau C, Michielsen PP, Flisiak R, Zondervan PE, Schalm SW, Janssen HL; HBV 99-01 Study Group. Buster EH, et al. Among authors: flisiak r. Hepatology. 2007 Aug;46(2):388-94. doi: 10.1002/hep.21723. Hepatology. 2007. PMID: 17604363 Clinical Trial.

3

Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.

ter Borg MJ, Hansen BE, Herrmann E, Zeuzem S, Cakaloglu Y, Karayalcin S, Flisiak R, van' t Veen A, de Man RA, Schalm SW, Janssen HL, Haagmans BL; HBV 99-01 Study Group. ter Borg MJ, et al. Among authors: flisiak r. Antivir Ther. 2007;12(8):1285-94. Antivir Ther. 2007. PMID: 18240868

4

Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.

Lapinski TW, Parfieniuk A, Rogalska-Plonska M, Czajkowska J, Flisiak R. Lapinski TW, et al. Among authors: flisiak r. Liver Int. 2009 Sep;29(8):1158-61. doi: 10.1111/j.1478-3231.2009.02052.x. Epub 2009 Jul 7. Liver Int. 2009. PMID: 19602133

5

Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C.

Panasiuk A, Parfieniuk A, Zak J, Flisiak R. Panasiuk A, et al. Among authors: flisiak r. Liver Int. 2010 Mar;30(3):472-8. doi: 10.1111/j.1478-3231.2009.02159.x. Epub 2009 Nov 16. Liver Int. 2010. PMID: 19919570

6

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M. Jaroszewicz J, et al. Among authors: flisiak r. J Hepatol. 2010 Apr;52(4):514-22. doi: 10.1016/j.jhep.2010.01.014. Epub 2010 Feb 13. J Hepatol. 2010. PMID: 20207438

7

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.

Rijckborst V, Hansen BE, Cakaloglu Y, Ferenci P, Tabak F, Akdogan M, Simon K, Akarca US, Flisiak R, Verhey E, Van Vuuren AJ, Boucher CA, ter Borg MJ, Janssen HL. Rijckborst V, et al. Among authors: flisiak r. Hepatology. 2010 Aug;52(2):454-61. doi: 10.1002/hep.23722. Hepatology. 2010. PMID: 20683945 Clinical Trial.

8

Prevalence and risk factors of HCV infection in Poland.

Flisiak R, Halota W, Horban A, Juszczyk J, Pawlowska M, Simon K. Flisiak R, et al. Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1213-7. doi: 10.1097/MEG.0b013e32834d173c. Eur J Gastroenterol Hepatol. 2011. PMID: 22002000

9

Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial.

Manns M, Reesink H, Berg T, Dusheiko G, Flisiak R, Marcellin P, Moreno C, Lenz O, Meyvisch P, Peeters M, Sekar V, Simmen K, Verloes R. Manns M, et al. Among authors: flisiak r. Antivir Ther. 2011;16(7):1021-33. doi: 10.3851/IMP1894. Antivir Ther. 2011. PMID: 22024518 Clinical Trial.

10

Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders.

Rijckborst V, Ferenci P, Akdogan M, Pinarbasi B, ter Borg MJ, Simon K, Flisiak R, Akarca US, Raptopoulou-Gigi M, Verhey E, van Vuuren AJ, Boucher CA, Hansen BE, Janssen HL; PARC Study Group. Rijckborst V, et al. Among authors: flisiak r. Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1012-9. doi: 10.1097/MEG.0b013e3283557e23. Eur J Gastroenterol Hepatol. 2012. PMID: 22668876 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

460 results

Search Page